▶ 調査レポート

世界のエピナスチン塩酸塩原薬市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Epinastine Hydrochloride API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のエピナスチン塩酸塩原薬市場2023年:企業・地域・種類・用途別分析 / Global Epinastine Hydrochloride API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z0595資料のイメージです。• レポートコード:MRC309Z0595
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界のエピナスチン塩酸塩原薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のエピナスチン塩酸塩原薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- エピナスチン塩酸塩原薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

エピナスチン塩酸塩原薬市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・純度≧99%、純度<99%

用途別セグメント
・点眼薬、錠剤、顆粒剤、カプセル剤

主要な市場プレーヤー
・Sun Pharmaceutical Industries Ltd、Trifarma Spa、Icrom Srl、Excella Gmbh And Co Kg、Boehringer Ingelheim Pharma Gmbh And Co Kg、Chongqing Kailin Pharmaceutical、Chongqing Ruibolai Pharmaceutical、Jiaozuo Mingren Natural Medicine

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、エピナスチン塩酸塩原薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエピナスチン塩酸塩原薬メーカーの企業概要、2019年~2022年までのエピナスチン塩酸塩原薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエピナスチン塩酸塩原薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別エピナスチン塩酸塩原薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのエピナスチン塩酸塩原薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのエピナスチン塩酸塩原薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびエピナスチン塩酸塩原薬の産業チェーンを掲載しています。
・第14、15章では、エピナスチン塩酸塩原薬の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- エピナスチン塩酸塩原薬の概要
- 種類別分析(2018年vs2022年vs2029年):純度≧99%、純度<99%
- 用途別分析(2018年vs2022年vs2029年):点眼薬、錠剤、顆粒剤、カプセル剤
- 世界のエピナスチン塩酸塩原薬市場規模・予測
- 世界のエピナスチン塩酸塩原薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Sun Pharmaceutical Industries Ltd、Trifarma Spa、Icrom Srl、Excella Gmbh And Co Kg、Boehringer Ingelheim Pharma Gmbh And Co Kg、Chongqing Kailin Pharmaceutical、Chongqing Ruibolai Pharmaceutical、Jiaozuo Mingren Natural Medicine
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:純度≧99%、純度<99%
・用途別分析2018年-2029年:点眼薬、錠剤、顆粒剤、カプセル剤
・エピナスチン塩酸塩原薬の北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・エピナスチン塩酸塩原薬のヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・エピナスチン塩酸塩原薬のアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エピナスチン塩酸塩原薬の南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・エピナスチン塩酸塩原薬の中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Epinastine Hydrochloride API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Epinastine Hydrochloride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Epinastine Hydrochloride API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Epinastine Hydrochloride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Epinastine Hydrochloride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Epinastine Hydrochloride API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epinastine Hydrochloride API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epinastine Hydrochloride API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sun Pharmaceutical Industries Ltd, Trifarma Spa, Icrom Srl, Excella Gmbh And Co Kg and Boehringer Ingelheim Pharma Gmbh And Co Kg, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Epinastine Hydrochloride API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99% Market segment by Application Eye Drops Tablet Granules Capsules Major players covered Sun Pharmaceutical Industries Ltd Trifarma Spa Icrom Srl Excella Gmbh And Co Kg Boehringer Ingelheim Pharma Gmbh And Co Kg Chongqing Kailin Pharmaceutical Chongqing Ruibolai Pharmaceutical Jiaozuo Mingren Natural Medicine Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Epinastine Hydrochloride API product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Epinastine Hydrochloride API, with price, sales, revenue and global market share of Epinastine Hydrochloride API from 2018 to 2023. Chapter 3, the Epinastine Hydrochloride API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Epinastine Hydrochloride API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Epinastine Hydrochloride API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Epinastine Hydrochloride API. Chapter 14 and 15, to describe Epinastine Hydrochloride API sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Epinastine Hydrochloride API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Epinastine Hydrochloride API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99% 1.4 Market Analysis by Application 1.4.1 Overview: Global Epinastine Hydrochloride API Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Eye Drops 1.4.3 Tablet 1.4.4 Granules 1.4.5 Capsules 1.5 Global Epinastine Hydrochloride API Market Size & Forecast 1.5.1 Global Epinastine Hydrochloride API Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Epinastine Hydrochloride API Sales Quantity (2018-2029) 1.5.3 Global Epinastine Hydrochloride API Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Sun Pharmaceutical Industries Ltd 2.1.1 Sun Pharmaceutical Industries Ltd Details 2.1.2 Sun Pharmaceutical Industries Ltd Major Business 2.1.3 Sun Pharmaceutical Industries Ltd Epinastine Hydrochloride API Product and Services 2.1.4 Sun Pharmaceutical Industries Ltd Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates 2.2 Trifarma Spa 2.2.1 Trifarma Spa Details 2.2.2 Trifarma Spa Major Business 2.2.3 Trifarma Spa Epinastine Hydrochloride API Product and Services 2.2.4 Trifarma Spa Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Trifarma Spa Recent Developments/Updates 2.3 Icrom Srl 2.3.1 Icrom Srl Details 2.3.2 Icrom Srl Major Business 2.3.3 Icrom Srl Epinastine Hydrochloride API Product and Services 2.3.4 Icrom Srl Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Icrom Srl Recent Developments/Updates 2.4 Excella Gmbh And Co Kg 2.4.1 Excella Gmbh And Co Kg Details 2.4.2 Excella Gmbh And Co Kg Major Business 2.4.3 Excella Gmbh And Co Kg Epinastine Hydrochloride API Product and Services 2.4.4 Excella Gmbh And Co Kg Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Excella Gmbh And Co Kg Recent Developments/Updates 2.5 Boehringer Ingelheim Pharma Gmbh And Co Kg 2.5.1 Boehringer Ingelheim Pharma Gmbh And Co Kg Details 2.5.2 Boehringer Ingelheim Pharma Gmbh And Co Kg Major Business 2.5.3 Boehringer Ingelheim Pharma Gmbh And Co Kg Epinastine Hydrochloride API Product and Services 2.5.4 Boehringer Ingelheim Pharma Gmbh And Co Kg Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Boehringer Ingelheim Pharma Gmbh And Co Kg Recent Developments/Updates 2.6 Chongqing Kailin Pharmaceutical 2.6.1 Chongqing Kailin Pharmaceutical Details 2.6.2 Chongqing Kailin Pharmaceutical Major Business 2.6.3 Chongqing Kailin Pharmaceutical Epinastine Hydrochloride API Product and Services 2.6.4 Chongqing Kailin Pharmaceutical Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Chongqing Kailin Pharmaceutical Recent Developments/Updates 2.7 Chongqing Ruibolai Pharmaceutical 2.7.1 Chongqing Ruibolai Pharmaceutical Details 2.7.2 Chongqing Ruibolai Pharmaceutical Major Business 2.7.3 Chongqing Ruibolai Pharmaceutical Epinastine Hydrochloride API Product and Services 2.7.4 Chongqing Ruibolai Pharmaceutical Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Chongqing Ruibolai Pharmaceutical Recent Developments/Updates 2.8 Jiaozuo Mingren Natural Medicine 2.8.1 Jiaozuo Mingren Natural Medicine Details 2.8.2 Jiaozuo Mingren Natural Medicine Major Business 2.8.3 Jiaozuo Mingren Natural Medicine Epinastine Hydrochloride API Product and Services 2.8.4 Jiaozuo Mingren Natural Medicine Epinastine Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Jiaozuo Mingren Natural Medicine Recent Developments/Updates 3 Competitive Environment: Epinastine Hydrochloride API by Manufacturer 3.1 Global Epinastine Hydrochloride API Sales Quantity by Manufacturer (2018-2023) 3.2 Global Epinastine Hydrochloride API Revenue by Manufacturer (2018-2023) 3.3 Global Epinastine Hydrochloride API Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Epinastine Hydrochloride API by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Epinastine Hydrochloride API Manufacturer Market Share in 2022 3.4.2 Top 6 Epinastine Hydrochloride API Manufacturer Market Share in 2022 3.5 Epinastine Hydrochloride API Market: Overall Company Footprint Analysis 3.5.1 Epinastine Hydrochloride API Market: Region Footprint 3.5.2 Epinastine Hydrochloride API Market: Company Product Type Footprint 3.5.3 Epinastine Hydrochloride API Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Epinastine Hydrochloride API Market Size by Region 4.1.1 Global Epinastine Hydrochloride API Sales Quantity by Region (2018-2029) 4.1.2 Global Epinastine Hydrochloride API Consumption Value by Region (2018-2029) 4.1.3 Global Epinastine Hydrochloride API Average Price by Region (2018-2029) 4.2 North America Epinastine Hydrochloride API Consumption Value (2018-2029) 4.3 Europe Epinastine Hydrochloride API Consumption Value (2018-2029) 4.4 Asia-Pacific Epinastine Hydrochloride API Consumption Value (2018-2029) 4.5 South America Epinastine Hydrochloride API Consumption Value (2018-2029) 4.6 Middle East and Africa Epinastine Hydrochloride API Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 5.2 Global Epinastine Hydrochloride API Consumption Value by Type (2018-2029) 5.3 Global Epinastine Hydrochloride API Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 6.2 Global Epinastine Hydrochloride API Consumption Value by Application (2018-2029) 6.3 Global Epinastine Hydrochloride API Average Price by Application (2018-2029) 7 North America 7.1 North America Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 7.2 North America Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 7.3 North America Epinastine Hydrochloride API Market Size by Country 7.3.1 North America Epinastine Hydrochloride API Sales Quantity by Country (2018-2029) 7.3.2 North America Epinastine Hydrochloride API Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 8.2 Europe Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 8.3 Europe Epinastine Hydrochloride API Market Size by Country 8.3.1 Europe Epinastine Hydrochloride API Sales Quantity by Country (2018-2029) 8.3.2 Europe Epinastine Hydrochloride API Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Epinastine Hydrochloride API Market Size by Region 9.3.1 Asia-Pacific Epinastine Hydrochloride API Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Epinastine Hydrochloride API Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 10.2 South America Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 10.3 South America Epinastine Hydrochloride API Market Size by Country 10.3.1 South America Epinastine Hydrochloride API Sales Quantity by Country (2018-2029) 10.3.2 South America Epinastine Hydrochloride API Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Epinastine Hydrochloride API Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Epinastine Hydrochloride API Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Epinastine Hydrochloride API Market Size by Country 11.3.1 Middle East & Africa Epinastine Hydrochloride API Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Epinastine Hydrochloride API Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Epinastine Hydrochloride API Market Drivers 12.2 Epinastine Hydrochloride API Market Restraints 12.3 Epinastine Hydrochloride API Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Epinastine Hydrochloride API and Key Manufacturers 13.2 Manufacturing Costs Percentage of Epinastine Hydrochloride API 13.3 Epinastine Hydrochloride API Production Process 13.4 Epinastine Hydrochloride API Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Epinastine Hydrochloride API Typical Distributors 14.3 Epinastine Hydrochloride API Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer